I think a good question is whether the product is not trusted or the company is not trusted, mostly the company, since approvals and partnerships have validated the product, only product issue left then is shelf life and ability to launch, if management achieves a launch, and Swiss Medic and Canada turn around on the shelf life issue, then the product and company will have proven themselves, IMO